Better Mitochondria, Not Just More: Urolithin A’s Human Trial Explained
In this Deep Dive episode, Dr. Mike breaks down a landmark first-in-human study on urolithin A — one of the most important translational steps yet in mitochondrial longevity science. The paper asks the question the field has been waiting for: when you target mitophagy (the selective cleanup of damaged mitochondria) in real humans, does it appear safe, does it reach the bloodstream and tissue, and does it actually shift biology in the direction of healthier mitochondrial function?
You’ll learn why urolithin A is different from typical “mitochondria boosters,” how the study tested safety…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.